The prevalence of glaucoma in patients undergoing surgery for eyelid entropion or ectropion

摘要

Purpose and design: The aim of this study was to establish the prevalence of known glaucoma in patients undergoing ectropion or entropion surgical repair. In this study, retrospective review of case series was performed. Participants: All patients who underwent ectropion or entropion surgery in a tertiary medical center between 2007 and 2014 were included. The etiology of eyelid malpositioning was involutional or cicatricial. Methods: The medical files of the study participants were reviewed for the presence and type of glaucoma, medical treatment, duration of treatment, and the amount of drops per day. These data were compared to a matched control group of 101 patients who underwent blepharoplasty for dermatochalasis in the same department during the same period. Main outcome measure: In this study, the prevalence of glaucoma in individuals with?ectropion or entropion was the main outcome measure. Results: A total of 227 patients (57% men, mean age: 79.2?years) who underwent ectropion or entropion surgery comprised the study group and 101 patients who underwent upper blepharoplasty for dermatochalasis comprised the control group. Compared to four patients in the control group (4%, P =0.01), 30 of the study patients (13.2%) had coexisting glaucoma. Of 30?glaucomatous patients, 25 had primary open-angle glaucoma for a mean duration of 10.3?years. The glaucomatous patients were treated with an average of 2.7 antiglaucoma medications. Conclusion: An increased prevalence of known glaucoma in patients undergoing ectropion or entropion repair surgery was found. This observation may indicate that the chronic usage of topical anti-glaucoma eyedrops may lead to an increased risk of developing eyelid malpositions, especially in elderly patients.